Tandem Diabetes Care (TNDM) EBIT (QoQ) (2013 - 2026)
Tandem Diabetes Care (TNDM) EBIT (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.39 Bn | 196.79 Bn | 7.27 Bn |
| 2 | Stryker | 126.37 Bn | 122.89 Bn | 4.50 Bn |
| 3 | Medtronic | 119.28 Bn | 110.06 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.63 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.65 Bn | 47.40 Bn | 1.35 Bn |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.89% |
| Mar 31, 2026 | -310.20% |
| Dec 31, 2025 | 136.28% |
| Sep 30, 2025 | 55.87% |
| Jun 30, 2025 | 57.14% |
| Mar 31, 2025 | -20,705.16% |
| Dec 31, 2024 | 97.77% |
| Sep 30, 2024 | 15.21% |
| Jun 30, 2024 | 26.16% |
| Mar 31, 2024 | -18.88% |
| Dec 31, 2023 | -11.14% |
| Sep 30, 2023 | 18.72% |
| Jun 30, 2023 | 69.64% |
| Mar 31, 2023 | -619.00% |
| Dec 31, 2022 | 62.57% |
| Sep 30, 2022 | -288.05% |
| Jun 30, 2022 | 20.20% |
| Mar 31, 2022 | -220.41% |
| Dec 31, 2021 | 65.00% |
| Sep 30, 2021 | 42.12% |